DE BERTI JACCHIA WITH LABORATORIO FARMACEUTICO SIT IN THE ACQUISITION OF DERINOX

team valletta Uncategorized

Laboratorio Farmaceutico SIT (“SIT”) announces the acquisition of the pharmaceutical product DERINOX from Therabel Lucien Pharma Sas, a reference medicine among topical decongestants. The product is indicated for the short-term symptomatic local treatment of congestive and inflammatory conditions during acute rhinitis, in adults and adolescents over 15 years of age. This acquisition will enable SIT to strengthen and expand its …